Cost benefit analysis of increasing the uptake of LARC in Australia

Research status


Overview of Study

Long-acting reversible contraceptives (LARCs) are highly effective in preventing pregnancy; however, uptake remains relatively low in Australia.

A cost-benefit analysis was undertaken to assess the impact of two scenarios for Australian women (over five years), with economic modelling based on the latest published contraception rates and discontinuation rates.

Scenario 1: Switching from an oral contraceptive pill to a LARC.

Scenario 2: Initiating the use of a LARC for women not currently using any form of contraception.

The additional impact of 20% of the increase in LARC insertions being carried out by RNs was also modelled.


Centre for International Economics (CIE)

Contact Details

If you would like more information, please contact:

Jessica Botfield (FPNSW):    

Share this page: Share page with AddThis

Find health


Request an



a course

Resources in

your language

Call or email Talkline